Factors related to an inadequate response to hepatitis B vaccination in health care personnel;Factores asociados a una respuesta inadecuada a la vacunacion contra la hepatitis ben personal sanitario

Revista Espanola de Salud Publica

Volumn 72, Issue 6, 1998, Pages 509-515

  Martínez, Natividad Tolosa ^a,b   Burillo, José María Tenías ^a   Bermúdez, Brígido Pérez ^a   Bautista, Juan ^a   Álvarez, Sanchis ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b Seccion de Medicina Preventiva   (Spain)

Author keywords

Health Care Personnel; Hepatitis B; Immunogenicity; Predicting Factors; Vaccination

Indexed keywords

HEPATITIS B VACCINE;

ACTIVE IMMUNIZATION; ADULT; ANTIBODY TITER; ARTICLE; DRUG EFFICACY; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HEPATITIS B; HUMAN; IMMUNOGENICITY; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE;

EID: 6544281580     PISSN: 11355727     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1135-57271998000600004     Document Type: Article

References (24)

1. Grupo de Trabajo de Vacunación en et Adulto. Guía de vacunación en el adulto. Madrid: Sociedad Española de Medicina Preventiva, Salud Pública e Higiene; 1995: 63-67.
2. Gil A, Lasheras ML, Vizcaino MJ, del Rey J, Martín D Inmunogenicidad de la vacuna contra el virus de la hepatitis B en escolares de Madrid. Rev San Hig Pública 1992; 66 149-156.
3. Centers for Disease Control: Changing patterns of groups at high risk for hepatitis B in the United States. MMWR 1988; 37. 429-437.
4. Campins M, Armadans L, Bermejo B, Jardí R, Rosselló J, Vaqué J Inmunogenicidad de la vacuna recombiriante de la hepatitis B. Estudio en personal sanitario. Rev Esp Microbiol Clin 1991; 6: 381-384.
5. Centers for Disease Control: Update on hepatitis B prevention. Recommendation of the inmunization practices advisory committee. Ann Intern Med 1987; 107. 353-357
6. Morris CA, Oliver PR, Reynolds F, Selkon JB. Intradermal hepatitis B immunization with yeastderived vaccine: serolostcal response by sex and age. Epidemiol Infect 1989, 103 (2): 387-394.
7. Kramer A, Sommer D, Hahn EG, Riecken EO. German experimental hepatitis B vaccine-influence of variation of dosage schedule. sex and age differences on immunogenicity in health care workers. Klin Wochenschr 1986; 64(15). 688-694.
8. Chiaramonte M, Ngatchu T, Majori S, Baldo V, Moschen ME, Renzulli G, et al. Response to an extra dose of hepatitis B vaccine and specific antibody persistence in non-respondres to primary immunization. Scand J Gastroenterol 1995; 30 (6): 601-603.
9. Cleveland JL, Siex C, Lockwood SA, Gruninger SE, Chang SB, Neidle EA et al. Factors associated with hepatitis B vaccine response among dentists. J Dent Res 1994; 73 (5): 1029-1035.
10. Struve J, Aronsson B, Frenning B, Granath F, von Sydow M, Weiland O. Intramuscular versus intradermal administration of recombinant hepatitis B vaccine: a comparison of response rates and analysis of factors influencing the antibody response. Scand J Infect Dis 1992; 24 (4): 423-429.
11. Roome AJ, Walsh SJ, Canter ML, Hadler JL. Hepatitis B vaccine responsiveness in Conneticut public safety personnel. JAMA 1993; 270 (24): 2931-2934.
12. Hess G, Hingst V, Cseke J, Bock HL. Clemens R. Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination. Eur J Clin Microbiol Infect Dis 1992; 11 (4): 334-340.
13. Shaw FE Jr, Guess HA, Roets JM, Mohr FE, Coleman PJ, Mandel EJ et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 1989; 7 (5): 425-430.
14. Hollinger FB. Factors influencing the inmune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. Am J Med 1989; 87 (3A): 36S-40S.
15. Alerany C, Zara C, Gnfell E, Guarga A. Vacunación contra el virus de la hepatitis B del personal sanitario y no sanitario en el àrea de Barcelona Ciudad. Aten Primaria 1993; 12: 480-486.
16. Bock HL, Kruppenbacher J, Sanger R, Hobel W, Clemens R, Jilg W. Inmunogenicity of a recombinant hepatitis B vaccine in adults. Arch Intern Med 1996; 156: 2226-2231.
17. Morales JM, Jaqueti J, Vina C, Revisión metaanalítica de la respuesta por sexo a la vacunación contra la hepatitis en personal hospitalario. Aten Primaria 1993; 12: 99-101.
18. Winter AP, Follett E, McIntyre J, Stewart J, Symington IS Influence of smoking on inmunological responses to hepatitis B vaccine. Vaccine 1994; 12 (9): 771-772.
19. De Rave S, Heijtink RA, Bakker-Bendik M, Boot J, Schalm SW. Immunogenicity of standard and low dose vaccination using yeast-derived recombinant hepatitis B surface antigen in elderly volunteers. Vaccine 1994; 12: 532-534.
20. Navarro JF, Teruel JL, Hepatitis B vaccine, hepatitis C virus infection, and haemodialysis Letter. Lancet 1995; 346: 845.
21. Navarro JF, Teruel JL, Mateos M, Ortuño J. Hepatitis C virus infection decreases the effective antibody response to hepatitis B vaccine in hemodialysis patients. Clin Nephrol 1994; 41 (2): 113-116.
22. Peces R, de la Torre M, Alcázar R, Urra JM. Prospective analysis of the factors influencing the antibody response to hepatitis 8 vaccine in hemodialysis patients. Am J Kidney Dis 1997; 29 (2): 239-245.
23. Alimonos K, Nafziger AN, Murray J, Bertino JS Jr. Prediction of response to hepatitis B vaccine in health care workers: whose titers of antibody to hepatitis B surface antigen should be determinated after a three-dose series, and what are the implications in terms of cost-effectivenes? Clin Infec Dis 1998; 26: 566-571.
24. Bertino JS Jr, Tirrell P, Greenberg RN, Keyserling HL, Poland GA, Gump D et al. A comparative trial of standard or high-dose S subunit recombinant hepatitis B vaccine versus a vaccine containing S subunit. pre-S1 and pre-S2 particles for revaccination of healthy adult nonresponders. J Infect Dis 1997, 175 (3): 678-681.